In early to intermediate AMD patients, 94% of perturbations were lipid-related, with higher levels of large to extra-large HDL subparticles and apolipoprotein A1, and lower levels of VLDLs, triglycerides, and fatty acids. This evidence concerns the gene APOA1 and age-related macular degeneration.